REYKJAVIK, Iceland, Feb. 17, 2025 /PRNewswire/ — 3Z Pharmaceuticals today announced the publication of a transformative study in Neuropsychopharmacology, highlighting compelling scientific evidence that positions the mechanisms engaged by amlodipine, an L-type calcium channel blocker […]